1
|
Ahmad I, Nawaz N, Darwesh NM, ur Rahman S, Mustafa MZ, Khan SB, Patching SG. Overcoming challenges for amplified expression of recombinant proteins using Escherichia coli. Protein Expr Purif 2018; 144:12-18. [DOI: 10.1016/j.pep.2017.11.005] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2017] [Revised: 11/15/2017] [Accepted: 11/21/2017] [Indexed: 11/28/2022]
|
2
|
Saidijam M, Karimi Dermani F, Sohrabi S, Patching SG. Efflux proteins at the blood-brain barrier: review and bioinformatics analysis. Xenobiotica 2017; 48:506-532. [PMID: 28481715 DOI: 10.1080/00498254.2017.1328148] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
1. Efflux proteins at the blood-brain barrier provide a mechanism for export of waste products of normal metabolism from the brain and help to maintain brain homeostasis. They also prevent entry into the brain of a wide range of potentially harmful compounds such as drugs and xenobiotics. 2. Conversely, efflux proteins also hinder delivery of therapeutic drugs to the brain and central nervous system used to treat brain tumours and neurological disorders. For bypassing efflux proteins, a comprehensive understanding of their structures, functions and molecular mechanisms is necessary, along with new strategies and technologies for delivery of drugs across the blood-brain barrier. 3. We review efflux proteins at the blood-brain barrier, classified as either ATP-binding cassette (ABC) transporters (P-gp, BCRP, MRPs) or solute carrier (SLC) transporters (OATP1A2, OATP1A4, OATP1C1, OATP2B1, OAT3, EAATs, PMAT/hENT4 and MATE1). 4. This includes information about substrate and inhibitor specificity, structural organisation and mechanism, membrane localisation, regulation of expression and activity, effects of diseases and conditions and the principal technique used for in vivo analysis of efflux protein activity: positron emission tomography (PET). 5. We also performed analyses of evolutionary relationships, membrane topologies and amino acid compositions of the proteins, and linked these to structure and function.
Collapse
Affiliation(s)
- Massoud Saidijam
- a Department of Molecular Medicine and Genetics , Research Centre for Molecular Medicine, School of Medicine, Hamadan University of Medical Sciences , Hamadan , Iran and
| | - Fatemeh Karimi Dermani
- a Department of Molecular Medicine and Genetics , Research Centre for Molecular Medicine, School of Medicine, Hamadan University of Medical Sciences , Hamadan , Iran and
| | - Sareh Sohrabi
- a Department of Molecular Medicine and Genetics , Research Centre for Molecular Medicine, School of Medicine, Hamadan University of Medical Sciences , Hamadan , Iran and
| | - Simon G Patching
- b School of BioMedical Sciences and the Astbury Centre for Structural Molecular Biology, University of Leeds , Leeds , UK
| |
Collapse
|
3
|
Hiruma-Shimizu K, Shimizu H, Thompson GS, Kalverda AP, Patching SG. Deuterated detergents for structural and functional studies of membrane proteins: Properties, chemical synthesis and applications. Mol Membr Biol 2016; 32:139-55. [DOI: 10.3109/09687688.2015.1125536] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Affiliation(s)
| | - Hiroki Shimizu
- Bioproduction Research Institute, National Institute of Advanced Industrial Science and Technology, Hokkaido, Japan,
| | - Gary S. Thompson
- School of Molecular and Cellular Biology, University of Leeds, Leeds, UK,
- Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK, and
| | - Arnout P. Kalverda
- School of Molecular and Cellular Biology, University of Leeds, Leeds, UK,
- Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, UK, and
| | | |
Collapse
|
4
|
|
5
|
Hiruma-Shimizu K, Kalverda AP, Henderson PJF, Homans SW, Patching SG. Synthesis of uniformly deuteratedn-dodecyl-β-d-maltoside (d39-DDM) for solubilization of membrane proteins in TROSY NMR experiments. J Labelled Comp Radiopharm 2014; 57:737-43. [DOI: 10.1002/jlcr.3249] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2014] [Revised: 10/21/2014] [Accepted: 11/06/2014] [Indexed: 01/07/2023]
Affiliation(s)
- Kazumi Hiruma-Shimizu
- School of Molecular and Cellular Biology; University of Leeds; Leeds UK
- Astbury Centre for Structural Molecular Biology; University of Leeds; Leeds UK
- Waseda University; Tokyo Japan
| | - Arnout P. Kalverda
- School of Molecular and Cellular Biology; University of Leeds; Leeds UK
- Astbury Centre for Structural Molecular Biology; University of Leeds; Leeds UK
| | - Peter J. F. Henderson
- School of Biomedical Sciences; University of Leeds; Leeds UK
- Astbury Centre for Structural Molecular Biology; University of Leeds; Leeds UK
| | - Steve W. Homans
- School of Molecular and Cellular Biology; University of Leeds; Leeds UK
- Astbury Centre for Structural Molecular Biology; University of Leeds; Leeds UK
- Newcastle University; Newcastle UK
| | | |
Collapse
|
6
|
Kalverda AP, Gowdy J, Thompson GS, Homans SW, Henderson PJF, Patching SG. TROSY NMR with a 52 kDa sugar transport protein and the binding of a small-molecule inhibitor. Mol Membr Biol 2014; 31:131-40. [DOI: 10.3109/09687688.2014.911980] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
7
|
Kroncke BM, Columbus L. Backbone ¹H, ¹³C and ¹⁵N resonance assignments of the α-helical membrane protein TM0026 from Thermotoga maritima. BIOMOLECULAR NMR ASSIGNMENTS 2013; 7:203-206. [PMID: 23011877 PMCID: PMC3543498 DOI: 10.1007/s12104-012-9410-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/18/2012] [Accepted: 07/16/2012] [Indexed: 06/01/2023]
Abstract
Critical to the use of solution NMR to describe the structure and flexibility of membrane proteins is the thorough understanding of the degree of perturbation induced by the detergent or other membrane mimetic. To develop a deeper understanding of the interaction between membrane proteins and micelles or bicelles, we will investigate the differences in structure and flexibility of a model membrane protein TM0026 from Thermotoga maritima using solution NMR. A comparison of the structural differences between TM0026 solubilized in different detergent combinations will provide important insight into the degree of modulation of membrane proteins by detergent physical properties. Here we report the nearly complete backbone and Cβ resonance assignments of the two transmembrane helical model protein TM0026. These assignments are the first step to using TM0026 to elucidate the interaction between membrane proteins and membrane mimetics.
Collapse
Affiliation(s)
| | - Linda Columbus
- To whom correspondence should be addressed. Linda Columbus: University of Virginia, Department of Chemistry, McCormick Rd, Charlottesville, VA, 22904, phone: (434) 243-2123, fax: (434) 924-3710,
| |
Collapse
|
8
|
Honarparvar B, Govender T, Maguire GEM, Soliman MES, Kruger HG. Integrated Approach to Structure-Based Enzymatic Drug Design: Molecular Modeling, Spectroscopy, and Experimental Bioactivity. Chem Rev 2013; 114:493-537. [DOI: 10.1021/cr300314q] [Citation(s) in RCA: 87] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Affiliation(s)
- Bahareh Honarparvar
- Catalysis
and Peptide Research Unit and ‡School of Health Sciences, University of KwaZulu Natal, Durban 4001, South Africa
| | - Thavendran Govender
- Catalysis
and Peptide Research Unit and ‡School of Health Sciences, University of KwaZulu Natal, Durban 4001, South Africa
| | - Glenn E. M. Maguire
- Catalysis
and Peptide Research Unit and ‡School of Health Sciences, University of KwaZulu Natal, Durban 4001, South Africa
| | - Mahmoud E. S. Soliman
- Catalysis
and Peptide Research Unit and ‡School of Health Sciences, University of KwaZulu Natal, Durban 4001, South Africa
| | - Hendrik G. Kruger
- Catalysis
and Peptide Research Unit and ‡School of Health Sciences, University of KwaZulu Natal, Durban 4001, South Africa
| |
Collapse
|
9
|
Structure determination of α-helical membrane proteins by solution-state NMR: emphasis on retinal proteins. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS 2013; 1837:578-88. [PMID: 23831435 DOI: 10.1016/j.bbabio.2013.06.009] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2013] [Accepted: 06/24/2013] [Indexed: 11/27/2022]
Abstract
The biochemical processes of living cells involve a numerous series of reactions that work with exceptional specificity and efficiency. The tight control of this intricate reaction network stems from the architecture of the proteins that drive the chemical reactions and mediate protein-protein interactions. Indeed, the structure of these proteins will determine both their function and interaction partners. A detailed understanding of the proximity and orientation of pivotal functional groups can reveal the molecular mechanistic basis for the activity of a protein. Together with X-ray crystallography and electron microscopy, NMR spectroscopy plays an important role in solving three-dimensional structures of proteins at atomic resolution. In the challenging field of membrane proteins, retinal-binding proteins are often employed as model systems and prototypes to develop biophysical techniques for the study of structural and functional mechanistic aspects. The recent determination of two 3D structures of seven-helical trans-membrane retinal proteins by solution-state NMR spectroscopy highlights the potential of solution NMR techniques in contributing to our understanding of membrane proteins. This review summarizes the multiple strategies available for expression of isotopically labeled membrane proteins. Different environments for mimicking lipid bilayers will be presented, along with the most important NMR methods and labeling schemes used to generate high-quality NMR spectra. The article concludes with an overview of types of conformational restraints used for generation of high-resolution structures of membrane proteins. This article is part of a Special Issue entitled: Retinal Proteins - You can teach an old dog new tricks.
Collapse
|
10
|
Siligardi G, Hussain R, Patching SG, Phillips-Jones MK. Ligand- and drug-binding studies of membrane proteins revealed through circular dichroism spectroscopy. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2013; 1838:34-42. [PMID: 23811229 DOI: 10.1016/j.bbamem.2013.06.019] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/15/2013] [Revised: 06/13/2013] [Accepted: 06/14/2013] [Indexed: 11/15/2022]
Abstract
A great number of membrane proteins have proven difficult to crystallise for use in X-ray crystallographic structural determination or too complex for NMR structural studies. Circular dichroism (CD) is a fast and relatively easy spectroscopic technique to study protein conformational behaviour. In this review examples of the applications of CD and synchrotron radiation CD (SRCD) to membrane protein ligand binding interaction studies are discussed. The availability of SRCD has been an important advancement in recent progress, most particularly because it can be used to extend the spectral region in the far-UV region (important for increasing the accuracy of secondary structure estimations) and for working with membrane proteins available in only small quantities for which SRCD has facilitated molecular recognition studies. Such studies have been accomplished by probing in the near-UV region the local tertiary structure of aromatic amino acid residues upon addition of chiral or non-chiral ligands using long pathlength cells of small volume capacity. In particular, this review describes the most recent use of the technique in the following areas: to obtain quantitative data on ligand binding (exemplified by the FsrC membrane sensor kinase receptor); to distinguish between functionally similar drugs that exhibit different mechanisms of action towards membrane proteins (exemplified by secretory phospholipase A2); and to identify suitable detergent conditions to observe membrane protein-ligand interactions using stabilised proteins (exemplified by the antiseptic transporter SugE). Finally, the importance of characterising in solution the conformational behaviour and ligand binding properties of proteins in both far- and near-UV regions is discussed. This article is part of a Special Issue entitled: Structural and biophysical characterisation of membrane protein-ligand binding.
Collapse
Affiliation(s)
- Giuliano Siligardi
- Diamond Light Source, Harwell Science and Innovation Campus, Didcot, Oxfordshire OX11 0DE, UK; School of Biological Sciences, University of Liverpool, Liverpool, UK.
| | | | | | | |
Collapse
|
11
|
Huang Q, Li Q, Chen AS, Kang C. West Nile virus protease activity in detergent solutions and application for affinity tag removal. Anal Biochem 2013; 435:44-6. [DOI: 10.1016/j.ab.2012.12.015] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2012] [Revised: 12/19/2012] [Accepted: 12/24/2012] [Indexed: 11/26/2022]
|
12
|
PatchinG SG, Henderson PJF, Sharples DJ, Middleton DA. Probing the contacts of a low-affinity substrate with a membrane-embedded transport protein using1H-13C cross-polarisation magic-angle spinning solid-state NMR. Mol Membr Biol 2012; 30:129-37. [DOI: 10.3109/09687688.2012.743193] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
13
|
Interactions of the intact FsrC membrane histidine kinase with its pheromone ligand GBAP revealed through synchrotron radiation circular dichroism. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 2012; 1818:1595-602. [DOI: 10.1016/j.bbamem.2012.02.015] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/18/2011] [Revised: 02/08/2012] [Accepted: 02/10/2012] [Indexed: 11/22/2022]
|
14
|
|
15
|
Kroncke BM, Columbus L. Identification and removal of nitroxide spin label contaminant: impact on PRE studies of α-helical membrane proteins in detergent. Protein Sci 2012; 21:589-95. [PMID: 22389096 DOI: 10.1002/pro.2038] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2011] [Revised: 01/23/2012] [Accepted: 01/24/2012] [Indexed: 11/06/2022]
Abstract
NMR paramagnetic relaxation enhancement (PRE) provides long-range distance constraints (~15-25 Å) that can be critical to determining overall protein topology, especially where long-range NOE information is unavailable such as in the case of larger proteins that require deuteration. However, several challenges currently limit the use of NMR PRE for α-helical membrane proteins. One challenge is the nonspecific association of the nitroxide spin label to the protein-detergent complex that can result in spurious PRE derived distance restraints. The effect of the nitroxide spin label contaminant is evaluated and quantified and a robust method for the removal of the contaminant is provided to advance the application of PRE restraints to membrane protein NMR structure determination.
Collapse
Affiliation(s)
- Brett M Kroncke
- Department of Chemistry, University of Virginia, Charlottesville, Virginia 22904, USA
| | | |
Collapse
|
16
|
Aigbirhio F, Appleyard MVCL, Arrowsmith RL, Baldwin SA, Bayrakdarian M, Botting NP, Cantin LD, Carbery DR, Carroll MA, Dixon LI, Dorff PN, Ellames G, Elmore CS, Fishwick CWG, Foot O, Geach NJ, Gowdy J, Grainger RS, Gregson T, Harker WRR, Henderson PJF, Heys JR, Homans SW, Hu Z, Jackson S, Johnston J, Johnson P, Kalverda A, Kay C, Kitson SL, Lanoue B, Levitt MH, Li Y, Lockley WJS, Luo X, Ma P, Middleton DA, Newsome J, Pandya B, Pascu SI, Patching SG, Phillips-Jones MK, Powell ME, Riss P, Simmons J, Simpson TM, Smith AD, Thompson AM, Trembleau L, Turtle R, Watters KW, Zhang Q. Abstracts of the 20th International Isotope Society (UK group) Symposium: Synthesis & Applications of Labelled Compounds 2011. J Labelled Comp Radiopharm 2012. [DOI: 10.1002/jlcr.2907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- F. Aigbirhio
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. V. C. L. Appleyard
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - R. L. Arrowsmith
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. A. Baldwin
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. Bayrakdarian
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - N. P. Botting
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - L. D. Cantin
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - D. R. Carbery
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. A. Carroll
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - L. I. Dixon
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. N. Dorff
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - G. Ellames
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - C. S. Elmore
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - C. W. G. Fishwick
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - O. Foot
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - N. J. Geach
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. Gowdy
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - R. S. Grainger
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - T. Gregson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - W. R. R. Harker
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. J. F. Henderson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. R. Heys
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. W. Homans
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - Z. Hu
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. Jackson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. Johnston
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. Johnson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - A. Kalverda
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - C. Kay
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. L. Kitson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - B. Lanoue
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. H. Levitt
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - Y. Li
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - W. J. S. Lockley
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - X Luo
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. Ma
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - D. A. Middleton
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. Newsome
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - B. Pandya
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. I. Pascu
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - S. G. Patching
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. K. Phillips-Jones
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - M. E. Powell
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - P. Riss
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - J. Simmons
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - T. M. Simpson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - A. D. Smith
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - A. M. Thompson
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - L. Trembleau
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - R. Turtle
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - K. W. Watters
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| | - Q. Zhang
- Division of Chemistry, Faculty of Health & Medical Sciences; University of Surrey; Guildford; Surrey; GU2 7XH; UK
| |
Collapse
|